We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hiscox Ltd | LSE:HSX | London | Ordinary Share | BMG4593F1389 | ORD 6.5P (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
14.00 | 1.28% | 1,108.00 | 1,111.00 | 1,113.00 | 1,117.00 | 1,091.00 | 1,097.00 | 683,372 | 16:35:13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Ins Agents,brokers & Service | 967.8M | 712M | 2.0959 | 5.31 | 3.72B |
Date | Subject | Author | Discuss |
---|---|---|---|
20/8/2024 08:21 | Sad news... sounds like Jonathan Bloomer was on board Mike Lynch's yacht..... | kirkie001 | |
15/8/2024 22:20 | It's saying competitors have experienced increased claims (environment) whereas Hiscox have not seen this | rdcdragon | |
07/8/2024 10:13 | "This has delivered a strong and increased underwriting result of $241 million, despite a more active loss environment, and positions us well to deliver high-quality growth through the insurance cycle."I don't understand this line. Are there any insurance experts out there who can shed light on the comment for me? | indiestu | |
08/7/2024 14:46 | At 6.5 times forward P.E. Still looks cheap | maximus3 | |
08/7/2024 11:47 | Many thanks | sspurt | |
08/7/2024 11:41 | Insurance Insider has the scoop this morning. https://www.insuranc | liam1om | |
08/7/2024 11:35 | and consistent with insurance industry insiders buying plus accelerating share repurchase programmes | sspurt | |
08/7/2024 11:32 | Can't find anything on my newsfeeds DFV but something must be going on | sspurt | |
08/7/2024 11:16 | Generali and Sompo both in play | dfvuk | |
14/12/2023 09:05 | Hiscox to use AI for underwriting process in tie-up with Google | premium beeks | |
14/12/2023 09:04 | https://www.ft.com/c | premium beeks | |
09/8/2023 12:43 | Market rewards it with a 8% fall. | bulltradept | |
09/8/2023 08:36 | Decent results | deadly | |
27/6/2023 07:53 | Hiscox? Has he more than one?? | volsung | |
09/8/2022 14:37 | Hiscox posted Interims last week. Gross premiums written increased by 9.2% to $2,649.8 million. Premium growth and portfolio adjustments lead to a strong underwriting result of $123.2 million (H1 2021: $99.8 million), up 23.4% on the prior period. The ultimate Group loss from all risks in Ukraine and Russia, including aviation, is $48 million net of reinsurance. The Group remains conservatively reserved with an 11.0% margin above actuarial best estimate and is strongly capitalised with BSCR of 200%. Investment performance was weak due to market conditions with a loss of $214.1m in the HY period. Valuation is average, the share price lacks momentum. HSX is a solid mid-cap insurance name and certainly worth monitoring, but there is no compelling rush to buy.... ...from WealthOracle | km18 | |
07/8/2022 17:44 | HSX doesn't seem to have taken the hit that other insurers are taking. Further to fall? | jmountain | |
03/8/2022 08:21 | Thoughts on these results anyone? | bulltradept | |
22/11/2021 20:43 | hTtps://www.itnews.c | beeks of arabia | |
28/9/2021 11:24 | Sentiment looks strongly against the sector currently, look at the LRE share price. I sold out of BEZ last week but will review on their early November update. BEZ looks particularly interesting in cyber, IF their recent better claims experience continues, however no recent BOD buying there. ec, thanks again for the info, much appreciated. | essentialinvestor | |
27/9/2021 14:24 | Yes, thanks Effortless. Very helpful. :) | medieval blacksmith | |
26/9/2021 13:49 | Very useful, thanks for highlighting. | essentialinvestor | |
24/9/2021 10:05 | An interesting article in "The Insurer" today, regarding Hiscox's exposure to possible non-payment of COVID loss recoveries by reinsurers. | effortless cool |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions